Literature DB >> 23386638

The paradox of prevention--bilateral atypical subtrochanteric fractures due to bisphosphonates in osteogenesis imperfecta.

Konstantinos N Manolopoulos1, Andrew West, Neil Gittoes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23386638     DOI: 10.1210/jc.2012-4195

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  7 in total

Review 1.  Osteogenesis imperfecta in children and adolescents-new developments in diagnosis and treatment.

Authors:  P Trejo; F Rauch
Journal:  Osteoporos Int       Date:  2016-08-05       Impact factor: 4.507

2.  Single dose of bisphosphonate preserves gains in bone mass following cessation of sclerostin antibody in Brtl/+ osteogenesis imperfecta model.

Authors:  Joseph E Perosky; Basma M Khoury; Terese N Jenks; Ferrous S Ward; Kai Cortright; Bethany Meyer; David K Barton; Benjamin P Sinder; Joan C Marini; Michelle S Caird; Kenneth M Kozloff
Journal:  Bone       Date:  2016-09-15       Impact factor: 4.398

3.  Management of atypical femoral fracture in a patient with osteogenesis imperfecta.

Authors:  Jing Yuan Tan; Cherng Jye Seow
Journal:  BMJ Case Rep       Date:  2017-12-20

4.  Osteogenesis imperfecta in adults.

Authors:  Nick J Bishop; Jennifer S Walsh
Journal:  J Clin Invest       Date:  2014-01-27       Impact factor: 14.808

5.  An atypical fracture in male patient with osteogenesis imperfecta.

Authors:  Iñigo Etxebarria-Foronda; Pedro Carpintero
Journal:  Clin Cases Miner Bone Metab       Date:  2015-12-29

6.  Atypical femur fracture in a woman with osteogenesis imperfecta and multiple myeloma.

Authors:  Yuxi Chen; Michael Sebag; Thomas I Powell; Suzanne N Morin
Journal:  J Musculoskelet Neuronal Interact       Date:  2018-09-01       Impact factor: 2.041

Review 7.  Genetic Risk Factors for Atypical Femoral Fractures (AFFs): A Systematic Review.

Authors:  Hanh H Nguyen; Denise M van de Laarschot; Annemieke JMH Verkerk; Frances Milat; M Carola Zillikens; Peter R Ebeling
Journal:  JBMR Plus       Date:  2018-01-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.